Podcast series

The ECNP podcast series brings you conversations with some of the leading researchers in applied neuroscience, discussing their work, their career, their vision on the field, and why they do what they do. 


Podcast 7 — Psychedelic research: the what, why and how*
Duration: 35 min

ecnp-stamp-podcast-blueFebruary 2023 — The use of psychedelics in the treatment of psychiatric disorders has been receiving widespread attention from the nonprofessional and scientific community for the last few years. The practice of taking a small, non-psychedelic dose of LSD or psilocybin to improve particular behaviour, emotions, or a psychiatric condition is claimed to be effective by its users. In this podcast Ilse Graat, the Netherlands, interviews Kim Kuypers, the Netherlands, on her path towards psychedelic, discussing where this young research field stands and where it is heading, including new research on microdosing yet to be explored.

Listen

Read more about Kim Kuypers and interviewer Ilse Graat.

* Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.

Podcast 6

ecnp-stamp-podcast-blue

January 2023 — In part one of the two-part podcast series, recorded during the 35th ECNP Congress 2022 in Vienna, PhD student Veerle van Gils, the Netherlands, and senior clinical scientist and psychologist Silke Matura, Germany, discuss the role of dysfunctional insulin signalling as modulator of mental and non-mental chronic diseases. They are both part of the PRIME (Prevention and Remediation of Insulin Multimorbidity in Europe) project trying to identify and specify the molecular mechanisms underlying insulin comorbidities.

Listen

 

ecnp-stamp-podcast-blue

January 2023 — Would you like to know ‘why we just don’t do the things we know are good for us'? Listen to part two of the podcast series with Silke Matura and Veerle van Gils.
Learn more on the effects of lifestyle on cognition and get familiar with the various techniques used to measure different types of cognition.

Listen

Read more about Veerle van Gils and Silke Matura.

*Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.

Podcast 5 — On what it was like to be an Early Career Scientist two decades ago, comorbidities in ADHD, being part of the ECNP Network ADHD across the lifespan and the impact of the pandemic*
Duration: 45 min

ecnp-stamp-podcast-blueMarch 2022 — Andreas Reif, Germany, past-chair of the Scientific Programme Committee (SPC), is in conversation with Early Career Advisory Panel (ECAP) past chair Nils Opel, Germany. Andreas Reif, who studies molecular underpinnings of neuropsychiatric disorders, talks about his life in science and how science has sped up since he started his career. In addition, he shares some advice on how to ensure a successful career start, elaborates on his participation in research networks and the impact of the Covid-19 pandemic on research and mental health.

Listen

Read more about Andreas Reif and interviewer Nils Opel.

*Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.

Podcast 4On the value of scientific work, collaboration and communication, the younger generation and being a woman in science*
Duration: 30 min

ecnp-stamp-podcast-blueMarch 2022 — ECNP President Gitte Moos Knudsen, Denmark talks about neurobiology, her personal career history and future plans.
Additionally, she gives advice to early career researchers on creating a successful career without neglecting personal life. 

Listen

Read more about Gitte Moos Knudsen and interviewer Sofi Atshemyan.

*Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.


Podcast 3 Mechanisms behind emotional processing and drug response in the treatment of depression and anxiety*
Duration: 45 min

ecnp-stamp-podcast-blueFebruary 2022Catherine Harmer, United Kingdom, talks about her personal research path and the major findings on the mechanisms behind emotional processing and depression. She also discusses the novel findings on the cognitive mechanisms of the response to drugs used in the treatment of depression and anxiety.

Listen

Read more about Catherine Harmer and interviewer Aiste Lengvenyte.

*Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.

Duration: 22 min

ecnp-stamp-podcast-blue

September 2021 — Declan Murphy, United Kingdom, is project coordinator of AIMS-2-TRIALS. The goal of the project is to better understand autism, to test new medicines, to better analyse data and to explore policies on autism. In this podcast, Prof Murphy shares his thoughts about the project and the future of autism research. 

Listen

*Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.

Inaugural podcast — On career, research, and the renaissance of psychedelics*
Duration: 36 min

ecnp-stamp-podcast-blue

March 2021 — David Nutt, United Kingdom, a leading expert in neuropsychopharmacology, shares his thoughts about the major findings in brain science and the future of psychiatry. He also talks about his curious path as a psychiatrist-turned-researcher and a fierce advocate for evidence-based treatments and policies.

Listen

Read more about David Nutt and interviewer Aiste Lengvenyte.

*Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.